InvestLog
Back to Market返回行情

IINN Inspira Technologies Oxy B.H.N. Ltd.

USHealthcare
$1.61-1.83%ClosedMarket Cap: $38.8M

As of 2026-06-26 09:30

Why IINN matters now

Inspira Technologies Oxy B.H.N. Ltd. (IINN) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.61 with -1.83% on the session and $38.8M in market capitalization; recent performance reads 1-month +392.11% and YTD +107.78%.

The latest financial table shown here is FY 2025, with revenue of $289.0K, net income of $-13.2M, and EPS of $-0.45. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield unavailable.

The latest indexable market news headline is "QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Rozanovich Yoav filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

—

PEG

—

P/B

—

P/S

—

EV/EBITDA

—

DCF Value

$0.11

FCF Yield

—

Div Yield

—

Margins & Returns

Gross Margin

—

Operating Margin

—

Net Margin

—

ROE

—

ROA

—

ROIC

—

Financials

PeriodRevenueNet IncomeEPS
FY 2025$289.0K$-13.2M$-0.45
Q2 2025$144.5K$-3.2M$-0.12
Q1 2025$144.5K$-3.2M$-0.12
FY 2024$0.00$-11.1K$-0.00

Analyst Ratings

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Rozanovich Yoavofficer
Sell2026-04-23
shabtay abrahamofficer: COO and VP of R&D
Sell2026-03-24
shabtay abrahamofficer: COO and VP of R&D
Sell2026-03-24
Ben-Noon Dagi Shahardirector, officer: Chief Executive Officer
Sell2026-03-19
Yechezkely Hayon Daniellaofficer: Chief Technology Officer
Sell2026-03-19

Related Stocks

COSM
Cosmos Health Inc.
$14.7M
ENLV
Enlivex Therapeutics Ltd.
$16.0M
FEMY
Femasys Inc.
$12.0M
IRIX
IRIDEX Corporation
$20.5M
LSTA
Lisata Therapeutics, Inc.
$31.4M

Latest News

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National SecurityGlobeNewsWire · 2026-07-06
QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load BarrierGlobeNewsWire · 2026-07-01
QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum ComputingGlobeNewsWire · 2026-06-09
QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in BostonGlobeNewsWire · 2026-06-02
QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related MaterialsGlobeNewsWire · 2026-06-01

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

—

Beta

2.16

Inspira Technologies Oxy B.H.N. Ltd. is a specialized medical device firm focused on developing, producing, and commercializing respiratory support systems. These systems offer a less invasive alternative to mechanical ventilation (MV) for patients suffering from respiratory failure. Its flagship offering is the Augmented Respiration Technology (ART) system, an innovative respiratory assistance device. The ART system employs a portable, minimally invasive dual-lumen cannula, which is strategically placed in the jugular vein to facilitate extracorporeal direct blood oxygenation, thereby effectively boosting and stabilizing critically low oxygen saturation levels. The company operated under the name Insense Medical Ltd. before rebranding as Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Established in 2018, Inspira Technologies maintains its headquarters in Ra'annana, Israel.